ABSTRACT Introduction: The 2018 Global Meningococcal Initiative (GMI) meeting focused
on evolving invasive meningococcal disease (IMD) epidemiology, surveillance, and …

Bacterial meningitis is a devastating infection, with a case fatality rate of up to 30% and 50%
of survivors developing neurological complications. These include short-term complications …

The degree of surveillance data and control strategies for invasive meningococcal disease
(IMD) varies across the Asia–Pacific region. IMD cases are often reported throughout the …

Outbreaks of invasive meningococcal disease (IMD) are unpredictable, can be sudden and
have devastating consequences. We conducted a non-systematic review of the literature in …

This narrative review describes the public health importance of four most common bacterial
meningitis agents, Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus …

Abstract In sub-Saharan Africa, bacterial meningitis remains a significant public health
problem, especially in the countries of the meningitis belt, where Neisseria meningitidis …

Neisseria meningitidis (Nm) remains a worldwide leading cause of epidemic meningitis.
During 2011–July 2021, 55 meningococcal disease (MD) cases were reported with a case …

Genomic surveillance of bacterial meningitis pathogens is essential for effective disease
control globally, enabling identification of emerging and expanding strains and consequent …

Whole-genome sequencing (WGS) is invaluable for studying the epidemiology of
meningococcal disease. Here we provide a perspective on the use of WGS for …

Abstract Background In 2010, Niger and other meningitis belt countries introduced a
meningococcal serogroup A conjugate vaccine (MACV). We describe the epidemiology of …